Vasodilatory effects of the selective GPER agonist G-1 is maximal in arteries of postmenopausal women

Maturitas

Volumn 78, Issue 2, 2014, Pages 123-130

  Arefin, Samsul ^a   Simoncini, Tommaso ^c   Wieland, Rebekah ^a   Hammarqvist, Folke ^b   Spina, Stefania ^c   Goglia, Lorenzo ^c   Kublickiene, Karolina ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Cardiovascular diseases; Endothelium; GPER; Smooth muscle; Vascular smooth muscle cells; Vasodilation

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; G PROTEIN COUPLED RECEPTOR 30; N(G) NITROARGININE METHYL ESTER; NORADRENALIN; RECEPTOR; ENZYME INHIBITOR; ESTROGEN; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GPER PROTEIN, HUMAN; NITRIC OXIDE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADULT; AGONIST; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOLATED ARTERY; MALE; MIDDLE AGED; POSTMENOPAUSE; PREGNANT WOMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; VASCULAR RESISTANCE; VASODILATATION; AGED; ANTAGONISTS AND INHIBITORS; ARTERY; DRUG EFFECTS; IN VITRO STUDY; METABOLISM; PHOSPHORYLATION; PREGNANCY; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

AGED; ARTERIES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ESTROGENS; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IN VITRO TECHNIQUES; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NOREPINEPHRINE; PHOSPHORYLATION; POSTMENOPAUSE; PREGNANCY; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASODILATION;

EID: 84901280200     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2014.04.002     Document Type: Article

References (40)

1. H.G. Dohlman, J. Thorner, and M.G. Caron et al. Model systems for the study of seven-transmembrane-segment receptors Annu Rev Biochem 60 1991 653 688
2. J.M. Hall, J.F. Couse, and K.S. Korach The multifaceted mechanisms of estradiol and estrogen receptor signaling J Biol Chem 276 2001 36869 36872
3. S. Nilsson, S. Mäkelä, and E. Treuter et al. Mechanisms of estrogen action Physiol Rev 81 2001 1535 1565
4. M.R. Meyer, O. Baretella, and E.R. Prossnitz et al. Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780 Pharmacology 86 2010 58 64
5. U.E. Mårtensson, S.A. Salehi, and S. Windahl et al. Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice Endocrinology 150 2009 687 698
6. B.R. Broughton, A.A. Miller, and C.G. Sobey Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries Am J Physiol Heart Circ Physiol 298 2010 H1055 H1061
7. Z.L. Li, J.C. Liu, and S.B. Liu et al. Improvement of vascular function by acute and chronic treatment with the GPR30 agonist G1 in experimental diabetes mellitus PLoS ONE 7 2012 e38787
8. E. Haas, M.R. Meyer, and U. Schurr et al. Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis Hypertension 49 2007 1358 1363
9. M.R. Meyer, K. Amann, and A.S. Field et al. Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction Hypertension 59 2012 507 512
10. C.G. Bologa, C.M. Revankar, and S.M. Young et al. Virtual and biomolecular screening converge on a selective agonist for GPR30 Nat Chem Biol 2 2006 207 212
11. S.H. Lindsey, K.A. Carver, and E.R. Prossnitz et al. Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2. Lewis female rat J Cardiovasc Pharmacol 57 2011 598 603
12. E. Haas, I. Bhattacharya, and E. Brailoiu et al. Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity Circ Res 104 2009 288 291
13. D. Grady, S.M. Rubin, and D.B. Petitti et al. Hormone therapy to prevent disease and prolong life in postmenopausal women Ann Intern Med 117 1992 1016 1037
14. J.E. Rossouw, G.L. Anderson, and R.L. Prentice et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
15. R.A. Hess Estrogen in the adult male reproductive tract: a review Reprod Biol Endocrinol 1 2003 52
16. B.J. Deroo, and K.S. Korach Estrogen receptors and human disease J Clin Invest 116 2006 561 570
17. K.L. Christensen, and M.J. Mulvany Location of resistance arteries J Vasc Res 38 2001 1 12
18. [Anonym] Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial JAMA 273 1995 199 208
19. D.E. Bush, C.E. Jones, and K.M. Bass et al. Estrogen replacement reverses endothelial dysfunction in postmenopausal women Am J Med 104 1998 552 558
20. N.G. Majmudar, S.C. Robson, and G.A. Ford Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity J Clin Endocrinol Metab 85 2000 1577 1583
21. L. Luksha, H. Nisell, and K. Kublickiene The mechanism of EDHF-mediated responses in subcutaneous small arteries from healthy pregnant women Am J Physiol Regul Integr Comp Physiol 286 2004 R1102 R1109
22. N.N. Lang, L. Luksha, and D.E. Newby et al. Connexin 43 mediates endothelium-derived hyperpolarizing factor-induced vasodilatation in subcutaneous resistance arteries from healthy pregnant women Am J Physiol Heart Circ Physiol 292 2007 H1026 H1032
23. N. Luksha, L. Luksha, and J.J. Carrero et al. Impaired resistance artery function in patients with end-stage renal disease Clin Sci (Lond) 120 2011 525 536
24. C. Skogastierna, L. Luksha, and K. Kublickiene et al. Beneficial vasoactive endothelial effects of fluvastatin: focus on prostacyclin and nitric oxide Heart Vessels 26 2011 628 636
25. L. Goglia, V. Tosi, and A.M. Sanchez et al. Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo Mol Hum Reprod 16 2010 761 769
26. X.D. Fu, and T. Simoncini Extra-nuclear signaling of estrogen receptors IUBMB Life 60 2008 502 510
27. 2+ influx and contraction in murine cardiomyocytes Am J Physiol Heart Circ Physiol 294 2008 H2421 H2427
28. R.H. Karas, H. Schulten, and G. Pare et al. Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice Circ Res 89 2001 534 539
29. E.R. Prossnitz, and M. Barton The G-protein-coupled estrogen receptor GPER in health and disease Nat Rev Endocrinol 7 2011 715 726
30. E. Filice, A.G. Recchia, and D. Pellegrino et al. A new membrane G protein-coupled receptor (GPR30) is involved in the cardiac effects of 17beta-estradiol in the male rat J Physiol Pharmacol 60 2009 3 10
31. S.H. Lindsey, J.A. Cohen, and K.B. Brosnihan et al. Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2. Lewis rats Endocrinology 150 2009 3753 3758
32. A. Rohrbach, I. Rubio, and M. Bulgay-Moerschel et al. Selective downregulation of phosphoinositide 3-kinase alpha in leukocytes during pregnancy Am J Reprod Immunol 61 2009 130 135
33. K.A. Hagedorn, C.L. Cooke, and J.R. Falck et al. Regulation of vascular tone during pregnancy: a novel role for the pregnane X receptor Hypertension 49 2007 328 333
34. S. Chakrabarti, and S.T. Davidge G-protein coupled receptor 30 (GPR30): a novel regulator of endothelial inflammation PLoS ONE 7 2012 e52357
35. Q. Ding, R. Gros, and L.E. Limbird et al. Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30 Am J Physiol Cell Physiol 297 2009 C1178 C1187
36. K. Kublickiene, E. Svedas, and B.M. Landgren et al. Small artery endothelial dysfunction in postmenopausal women: in vitro function, morphology, and modification by estrogen and selective estrogen receptor modulators J Clin Endocrinol Metab 90 2005 6113 6122
37. H. Sakaguchi, J. Fujimoto, and I. Aoki et al. Expression of estrogen receptor alpha and beta in myometrium of premenopausal and postmenopausal women Steroids 68 2003 11 19
38. M.N. Cruz, L. Luksha, and H. Logman et al. Acute responses to phytoestrogens in small arteries from men with coronary heart disease Am J Physiol Heart Circ Physiol 290 2006 H1969 H1975
39. L. Luksha, and K. Kublickiene The role of estrogen receptor subtypes for vascular maintenance Gynecol Endocrinol 25 2009 82 95
40. A.D. Pradhan, J.E. Manson, and J.E. Rossouw et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study JAMA 288 2002 980 987